In this study, we present a targeted drug delivery system to improve intravesical
therapy of
bladder diseases. The drug delivery system consists of
wheat germ agglutinin (WGA) to facilitate specific interaction with the surface of bladder cells and α-poly-(
L)-glutamic acid (
PGA) as polymeric backbone to increase the number of
drug molecules per targeting moiety. Additionally,
fluorescein cadaverine was coupled to
PGA to visualise and track the delivery system. Using 5637 single cells and cell monolayers, the optimised F-
PGA-WGA delivery system, with an approximate molecular weight of 670kDa, could convince with its promising cytoadhesive as well as cytoinvasive potential. Using the competitive inhibitor N, N', N″-triacetylchitotriose a specificity of the
carbohydrate-mediated interaction between the cell and the delivery system of up to 98% was determined. F-
PGA alone did not show any interaction with the cells. Moreover, a high
drug loading of 77 molecules of the model
drug Dansylcadaverine per backbone was achieved. Microscopic analysis further confirmed binding and uptake of the cytoadhesive
polymer even after additional loading with the model
drug. Combining the auspicious targeting properties of WGA with the high
drug loading possibilities of the backbone might finally lead to an enhanced efficacy when used for intravesical
therapy.